BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15226187)

  • 21. Chromosomal translocation t(11;14) and p53 deletion induced by the CRISPR/Cas9 system in normal B cell-derived iPS cells.
    Azami Y; Tsuyama N; Abe Y; Sugai-Takahashi M; Kudo KI; Ota A; Sivasundaram K; Muramatsu M; Shigemura T; Sasatani M; Hashimoto Y; Saji S; Kamiya K; Hanamura I; Ikezoe T; Onodera M; Sakai A
    Sci Rep; 2021 Mar; 11(1):5216. PubMed ID: 33664418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TAF1 histone acetyltransferase activity in Sp1 activation of the cyclin D1 promoter.
    Hilton TL; Li Y; Dunphy EL; Wang EH
    Mol Cell Biol; 2005 May; 25(10):4321-32. PubMed ID: 15870300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular detection of t(11;14)(q13;q32) in mantle cell lymphoma.
    Yin CC; Luthra R
    Methods Mol Biol; 2013; 999():211-6. PubMed ID: 23666700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sequestration of p27Kip1 protein by cyclin D1 in typical and blastic variants of mantle cell lymphoma (MCL): implications for pathogenesis.
    Quintanilla-Martinez L; Davies-Hill T; Fend F; Calzada-Wack J; Sorbara L; Campo E; Jaffe ES; Raffeld M
    Blood; 2003 Apr; 101(8):3181-7. PubMed ID: 12515730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overlapping morphologic and immunophenotypic profiles in small B-cell lymphoma. A report of two cases.
    Kostopoulos I; Cocco M; Ginanneschi C; D'Amuri A; Lazzi S; Fabbri A; Forconi F; De Santi MM; Leoncini L
    Virchows Arch; 2006 Sep; 449(3):320-7. PubMed ID: 16847683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular analysis of bcl-1/IgH junctional sequences in mantle cell lymphoma: potential mechanism of the t(11;14) chromosomal translocation.
    Stamatopoulos K; Kosmas C; Belessi C; Kyriazopoulos P; Papadaki T; Anagnostou D; Loukopoulos D
    Br J Haematol; 1999 Apr; 105(1):190-7. PubMed ID: 10233383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alterations of the cyclin D1/pRb/p16(INK4A) pathway in multiple myeloma.
    Krämer A; Schultheis B; Bergmann J; Willer A; Hegenbart U; Ho AD; Goldschmidt H; Hehlmann R
    Leukemia; 2002 Sep; 16(9):1844-51. PubMed ID: 12200702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of t(11;14) using interphase molecular cytogenetics in mantle cell lymphoma and atypical chronic lymphocytic leukemia.
    Avet-Loiseau H; Garand R; Gaillard F; Daviet A; Mellerin MP; Robillard N; Bouyge I; Arcot S; Batzer M; Talmant P; Harousseau JL; Milpied N; Bataille R
    Genes Chromosomes Cancer; 1998 Oct; 23(2):175-82. PubMed ID: 9739021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of cyclin D1 mRNA overexpression in B-cell neoplasias by real-time reverse transcription-PCR of microdissected paraffin sections.
    Specht K; Kremer M; Müller U; Dirnhofer S; Rosemann M; Höfler H; Quintanilla-Martinez L; Fend F
    Clin Cancer Res; 2002 Sep; 8(9):2902-11. PubMed ID: 12231535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new multiple myeloma cell line, MEF-1, possesses cyclin D1 overexpression and the p53 mutation.
    Yufu Y; Goto T; Choi I; Uike N; Kozuru M; Ohshima K; Taniguchi T; Motokura T; Yatabe Y; Nakamura S
    Cancer; 1999 Apr; 85(8):1750-7. PubMed ID: 10223569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation.
    Nguyen CT; Gonzales FA; Jones PA
    Nucleic Acids Res; 2001 Nov; 29(22):4598-606. PubMed ID: 11713309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional long-range interactions of the IgH 3' enhancers with the bcl-2 promoter region in t(14;18) lymphoma cells.
    Duan H; Xiang H; Ma L; Boxer LM
    Oncogene; 2008 Dec; 27(53):6720-8. PubMed ID: 18695675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epigenetic regulation of O6-methylguanine-DNA methyltransferase gene expression by histone acetylation and methyl-CpG binding proteins.
    Danam RP; Howell SR; Brent TP; Harris LC
    Mol Cancer Ther; 2005 Jan; 4(1):61-9. PubMed ID: 15657354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
    Zhang Y; Fatima N; Dufau ML
    Mol Cell Biol; 2005 Sep; 25(18):7929-39. PubMed ID: 16135786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclin D1 messenger RNA overexpression as a marker for mantle cell lymphoma.
    de Boer CJ; van Krieken JH; Kluin-Nelemans HC; Kluin PM; Schuuring E
    Oncogene; 1995 May; 10(9):1833-40. PubMed ID: 7753558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-kappaB/p65 DNA binding.
    Hu J; Colburn NH
    Mol Cancer Res; 2005 Feb; 3(2):100-9. PubMed ID: 15755876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclin D1 overexpression induces global transcriptional downregulation in lymphoid neoplasms.
    Albero R; Enjuanes A; Demajo S; Castellano G; Pinyol M; García N; Capdevila C; Clot G; Suárez-Cisneros H; Shimada M; Karube K; López-Guerra M; Colomer D; Beà S; Martin-Subero JI; Campo E; Jares P
    J Clin Invest; 2018 Aug; 128(9):4132-4147. PubMed ID: 29990311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor-specific transcript variants of cyclin D1 in mantle cell lymphoma and multiple myeloma with chromosome 11q13 abnormalities.
    Chinen Y; Tsukamoto T; Maegawa-Matsui S; Matsumura-Kimoto Y; Takimoto-Shimomura T; Tanba K; Mizuno Y; Fujibayashi Y; Kuwahara-Ota S; Shimura Y; Kobayashi T; Horiike S; Taniwaki M; Kuroda J
    Exp Hematol; 2020 Apr; 84():45-53.e1. PubMed ID: 32145384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kaiso represses the cell cycle gene cyclin D1 via sequence-specific and methyl-CpG-dependent mechanisms.
    Donaldson NS; Pierre CC; Anstey MI; Robinson SC; Weerawardane SM; Daniel JM
    PLoS One; 2012; 7(11):e50398. PubMed ID: 23226276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Malignant hematopoietic cell lines: in vitro models for the study of mantle cell lymphoma.
    Drexler HG; MacLeod RA
    Leuk Res; 2002 Sep; 26(9):781-7. PubMed ID: 12127550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.